Top

World Journal of Surgical Oncology

Published in:

Open Access 01-12-2013 | Research

A retrospective study: the prognostic value of anemia, smoking and drinking in esophageal squamous cell carcinoma with primary radiotherapy

Authors: Fang Zhang, Hui Han, Chuansheng Wang, Jianbo Wang, Guangyu Zhang, Fangli Cao, Yufeng Cheng

Published in: World Journal of Surgical Oncology | Issue 1/2013

Abstract

Background

Few studies have investigated the relationship between anemia, smoking, drinking and survival in esophageal squamous cell carcinoma (ESCC) with primary radiotherapy. This study had the aim of evaluating the prognostic value of anemia, smoking and drinking in patients receiving primary radiotherapy for ESCC.

Methods

A total of 79 patients who underwent radiotherapy during initial treatment for ESCC were included in this study. The 2-year overall survival (OS) and disease-free survival (DFS) were analyzed between the anemic and non-anemic groups, non-smokers and smokers, and non-drinkers and drinkers using the Kaplan-Meier method and the Cox proportional hazards model.

Results

There were 79 patients (10 male) of median age 63 (range 38 to 84) years. The 2-year OS and DFS were 36% and 25%, respectively, in the non-anemic group, and 17% and 13%, respectively, in the anemic group (P = 0.019 for OS; P = 0.029 for DFS) using the Kaplan-Meier method. Survival analysis using the Kaplan-Meier method showed that the 2-year OS and DFS had no statistical difference between smoking, drinking and survival. In a univariate analysis, anemia was identified as a significant prognostic factor for 2-year OS (hazard ratio (HR) = 1.897; P = 0.024) and 2-year DFS (HR = 1.776; P = 0.036), independent of tumor, lymph node, metastasis (TNM) stage. In a multivariate analysis, anemia was identified as a highly significant prognostic factor for 2-year OS (HR = 2.125; P = 0.011) and 2-year DFS (HR = 1.898; P = 0.025), independent of TNM stage and initial treatment. We found no statistical difference in the 2-year OS and DFS associated with smoking (P > 0.2) and drinking (P > 0.6) using univariate and multivariate analysis.

Conclusions

Smoking and drinking were not prognostic for 2-year OS or DFS. Anemia before radiotherapy was associated with poor prognosis and an increased risk of relapse, which may serve as a new prognostic characteristic in ESCC treated with primary radiotherapy. Hemoglobin is a routine examination and anemia is therefore simple and quick to determine.

Available only for authorised users

Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM: Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2008, 2010 (127): 2893-2917.

Yamaji T, Inoue M, Sasazuki S, Iwasaki M, Kurahashi N, Shimazu T, Tsugane S, Japan Public Health Center-based Prospective Study Group: Fruit and vegetables consumption and squamous cell carcinoma of the esophagus in Japan: the JPHC study. Int J Cancer. 2008, 123: 1935-1940. 10.1002/ijc.23744.CrossRefPubMed

Lu SH: Alterations of oncogenes and tumor suppressor genes in esophageal cancer in China. Mutat Res. 2000, 462: 343-353. 10.1016/S1383-5742(00)00023-5.CrossRefPubMed

Vaupel P, Thews O, Hoeckel M: Treatment resistance of solid tumours: roles of hypoxia and anemia. Med Oncol. 2001, 18: 243-249. 10.1385/MO:18:4:243.CrossRefPubMed

Fein DA, Lee WR, Hanlon AL, Ridge JA, Langer CJ, Curran WJ, Coia LR: Pretreatment hemoglobin level influences local control and survival of T1–T2 squamous cell carcinomas of the glottic larynx. J Clin Oncol. 1995, 13: 2077-2083.PubMed

Rice TW, Blackstone EH, Rusch VW: 7th edition of the AJCC Cancer Staging Manual: esophagus and esophagogastric junction. Ann Surg Oncol. 2010, 17: 1721-1724. 10.1245/s10434-010-1024-1.CrossRefPubMed

Walter CJ, Bell LT, Parsons SR, Jackson C, Borley NR, Wheeler JM: Prevalence and significance of anemia in patients receiving long-course neoadjuvant chemoradiotherapy for rectal carcinoma. Colorectal Dis. 2013, 15: 52-56. 10.1111/j.1463-1318.2012.03112.x.CrossRefPubMed

Dietl B, Marienhagen J, Schäfer C, Kölbl O: The prognostic value of anemia at different treatment times in patients with locally advanced head and neck cancer treated with surgery and postoperative radiotherapy. Clin Oncol. 2007, 19: 228-233. 10.1016/j.clon.2007.02.009.CrossRef

Dubray B, Mosseri V, Brunin F, Jaulerry C, Poncet P, Rodriguez J, Brugère J, Point D, Giraud P, Cosset JM: Anemia is associated with lower local-regional control and survival after radiation therapy for head and neck cancer: a prospective study. Radiology. 1996, 201: 553-558.CrossRefPubMed

10.

Grigiene R, Aleknavicius E, Kurtinaitis J: Prognostic value of anemia for patients with cervical cancer treated with irradiation. Medicina (Kaunas). 2005, 41: 916-924.

11.

MacRae R, Shyr Y, Johnson D, Choy H: Declining hemoglobin during chemoradiotherapy for locally advanced non-small cell lung cancer is significant. Radiother Oncol. 2002, 64: 37-40. 10.1016/S0167-8140(02)00151-2.CrossRefPubMed

12.

Zenda S, Hironaka S, Boku N, Yamazaki K, Yasui H, Fukutomi A, Yoshino T, Onozawa Y, Nishimura T: Impact of hemoglobin level on survival in definitive chemoradiotherapy for T4/M1 lymph node esophageal cancer. Dis Esophagus. 2008, 21: 195-200. 10.1111/j.1442-2050.2007.00750.x.CrossRefPubMed

13.

Zhao KL, Liu G, Jiang GL, Wang Y, Zhong LJ, Wang Y, Yao WQ, Guo XM, Wu GD, Zhu LX, Shi XH: Association of haemoglobin level with morbidity and mortality of patients with locally advanced oesophageal carcinoma undergoing radiotherapy - a secondary analysis of three consecutive clinical phase III trials. Clin Oncol. 2006, 18: 621-627. 10.1016/j.clon.2006.04.015.CrossRef

14.

Hofheinz RD, Raab B, Mai S, Wenz F, Willeke F, Emig M, Buchheidt D, Hehlmann R, Hochhaus A: Impact of chemoradiotherapy-induced anemia on survival in uniformly staged patients with locally advanced squamous cell carcinoma of the esophagus. Onkologie. 2004, 27: 462-466. 10.1159/000080366.CrossRefPubMed

15.

Kandaz M, Ertekin MV, Bilici M: Retrospective analysis of patients with esophageal cancer treated with radiotherapy and /or chemoradiotherapy. Tumori. 2012, 98: 445-450.PubMed

16.

Michalek AM, Cummings KM, Pontes JE: Cigarette smoking, tumor recurrence, and survival from bladder cancer. Prev Med. 1985, 14: 92-98. 10.1016/0091-7435(85)90024-6.CrossRefPubMed

17.

Vatten LJ, Foss OP, Kvinnsland S: Overall survival of breast cancer patients in relation to preclinically determined total serum cholesterol, body mass index, height and cigarette smoking: a population-based study. Eur J Cancer. 1991, 27: 641-646. 10.1016/0277-5379(91)90234-5.CrossRefPubMed

18.

Sundelöf M, Lagergren J, Ye W: Patient demographics and lifestyle factors influencing long-term survival of oesophageal cancer and gastric cardia cancer in a nationwide study in Sweden. Eur J Cancer. 2008, 44: 1566-1571. 10.1016/j.ejca.2008.04.002.CrossRefPubMed

19.

Samadi F, Babaei M, Yazdanbod A, Fallah M, Nouraie M, Nasrollahzadeh D, Sadjadi A, Derakhshan MH, Shokuhi B, Fuladi R, Malekzadeh R: Survival rate of gastric and esophageal cancers in Ardabil province, North-West of Iran. Arch Iran Med. 2007, 10: 32-37.PubMed

20.

Trivers KF, De Roos AJ, Gammon MD, Vaughan TL, Risch HA, Olshan AF, Schoenberg JB, Mayne ST, Dubrow R, Stanford JL, Abrahamson P, Rotterdam H, West AB, Fraumeni JF, Chow WH: Demographic and lifestyle predictors of survival in patients with esophageal or gastric cancers. Clin Gastroenterol Hepatol. 2005, 3: 225-230. 10.1016/S1542-3565(04)00613-5.CrossRefPubMed

21.

Tsai CH, Hsu HS, Wang LS, Wang HW, Wu YC, Hsieh CC, Huang BS, Hsu WH, Huang MH: Surgical results of squamous cell carcinoma of the esophagus in young patients. J Chin Med Assoc. 2003, 66: 288-293.PubMed

22.

Schoppmann SF, Jesch B, Zacherl J, Riegler MF, Friedrich J, Birner P: Lymphangiogenesis and lymphovascular invasion diminishes prognosis in esophageal cancer. Surg. 2013, 153: 526-534. 10.1016/j.surg.2012.10.007.CrossRef

23.

Wang K, Ma W, Wang J, Yu L, Zhang X, Wang Z, Tan B, Wang N, Bai B, Yang S, Liu H, Zhu S, Cheng Y: Tumor-stroma ratio is an independent predictor for survival in esophageal squamous cell carcinoma. J Thorac Oncol. 2012, 7: 1457-1461. 10.1097/JTO.0b013e318260dfe8.CrossRefPubMed

Title: A retrospective study: the prognostic value of anemia, smoking and drinking in esophageal squamous cell carcinoma with primary radiotherapy
Authors: Fang Zhang
Hui Han
Chuansheng Wang
Jianbo Wang
Guangyu Zhang
Fangli Cao
Yufeng Cheng
Publication date: 01-12-2013
Publisher: BioMed Central
Published in: World Journal of Surgical Oncology / Issue 1/2013
Electronic ISSN: 1477-7819
DOI: https://doi.org/10.1186/1477-7819-11-249

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

A retrospective study: the prognostic value of anemia, smoking and drinking in esophageal squamous cell carcinoma with primary radiotherapy

Abstract

Background

Methods

Results

Conclusions

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2013

Mesohepatectomy with total caudate lobectomy of the liver for hepatocellular carcinoma

Incomplete staging surgery as a major predictor of relapse of borderline ovarian tumor

Giant gastrointestinal stromal tumor (GIST) of the stomach cause of high bowel obstruction: surgical management

Contemporary adjuvant polymethyl methacrylate cementation optimally limits recurrence in primary giant cell tumor of bone patients compared to bone grafting: a systematic review and meta-analysis

Ganglioside-monosialic acid (GM1) prevents oxaliplatin-induced peripheral neurotoxicity in patients with gastrointestinal tumors

Locally-advanced primary neuroendocrine carcinoma of the breast: case report and review of the literature